Pathogens & Persistence: The Chronic Disease Drivers

Ticktective™ with Dana Parish

Dr. Steven Phillips

Steven E. Phillips, MD, is a Yale-trained expert on zoonotic infections and coauthor of the book CHRONIC. He specializes in treating medicine’s most complex cases, which include Lyme & other vector-borne disease and Long COVID. Additionally, he has served as an expert for the states of CT, NY, RI, and VT, providing testimony during their respective public hearings, which resulted in changes to existing healthcare laws. Dr. Phillips has been a longstanding public face of the Lyme pandemic. He is currently spearheading a drug development effort to bring the public a durable, effective treatment for some of these infections, which will hopefully change how we treat a range of rheumatologic and neurologic illnesses. Dr. Phillips also sits on the Bay Area Lyme Foundation’s scientific advisory board.

Matt Kaeberlein, Rapamycin, and the Dog Aging Project: What Animals Can Teach Us About Aging Better

Matt Kaeberlein

BAL “Quick Bites” Series

 

In scientific exploration, few fields captivate the imagination quite like the study of aging. It’s a universal process affecting all living beings, yet its mechanisms remain elusive and its implications profound. Recently, a spotlight has been cast on aging research through initiatives like the Dog Aging Project, spearheaded by Dr. Matt Kaeberlein. This ambitious endeavor aims not only to understand the biological underpinnings of aging in dogs but also to glean insights that could potentially enhance human longevity. At the forefront of this research is rapamycin, a drug with promising anti-aging properties. In our latest Ticktective interview, Dana Parish delves into the intricacies of this groundbreaking project with Dr. Kaeberlein and learns what animals, particularly dogs, can teach us about aging better.

“Investing in research on aging and companion animal health can pave the way for longer, healthier lives for both humans and animals.”

– Matt Kaeberlein

Ticktective with Dana Parish: Rapamycin, The Dog Aging Project: What Animals Can Teach Us About Aging Better

Ticktective™ with Dana Parish

Dr Matt Kaeberlein

Dr. Matt Kaeberlein is the Chief Executive Officer at Optispan, Inc., Affiliate Professor of Oral Health Sciences at the University of Washington, and Co-Director of the Dog Aging Project. Dr. Kaeberlein’s research interests are focused on understanding the biological mechanisms of aging to facilitate translational interventions that promote healthspan and improve the quality of life for people and companion animals. He is a Fellow of the American Association for the Advancement of Science (AAAS), the American Aging Association (AGE), and the Gerontological Society of America (GSA). Dr. Kaeberlein has published more than 250 peer-reviewed papers in the field of longevity and has received several prestigious awards including young investigator awards from the Ellison Medical Foundation and the Alzheimer’s Association, the Vincent Cristofalo Rising Star in Aging Research Award, the Murdock Trust Award, the NIA Nathan W. Shock Award, and the Robert W. Kleemeier Award for outstanding research in the field of gerontology. Dr. Kaeberlein is the founding Director of the University of Washington Healthy Aging and Longevity Research Institute, former Director of the NIH Nathan Shock Center of Excellence in the Basic Biology of Aging and the Biological Mechanisms of Healthy Aging Training Program at the University of Washington, and former CEO and Chair of the American Aging Association.